Study of Iomab-B vs. Conventional Care in Older Subjects With Active, Relapsed or Refractory Acute Myeloid Leukemia

Conditions

• Acute Myeloid Leukemia
• Leukemia, Acute Myeloid
• Myeloid Leukemia, Acute
• Leukemia, Myeloid, Acute
• Acute Myelogenous Leukemia
• Leukemia, Acute Myelogenous
• Myelogenous Leukemia, Acute
• AML
• Bone Marrow Transplant

Interventions

• DRUG: Iomab-B
• DRUG: Conventional Care
• PROCEDURE: HCT

Sponsor

Actinium Pharmaceuticals